Lpl Financial LLC Quotient LTD Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

Shares

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	BUY	$0.24 - $1.2 $400 - $2,002	1,669 Added 1.59%	106,315 $26,000
Q1 2022 May 16, 2022	SELL	$0.94 - $2.38 $841 - $2,130	-895 Reduced 0.85%	104,646 $126,000
Q4 2021 Feb 14, 2022	SELL	$1.89 - $3.12 $10,905 - $18,002	-5,770 Reduced 5.18%	105,541 $273,000
Q3 2021 Nov 15, 2021	BUY	$2.34 - $3.77 $10,597 - $17,074	4,529 Added 4.24%	111,311 $260,000
Q2 2021 Aug 13, 2021	BUY	$3.48 - $4.45 $17,584 - $22,485	5,053 Added 4.97%	106,782 $389,000
Q1 2021 May 14, 2021	BUY	$3.57 - $6.2 $18,931 - $32,878	5,303 Added 5.5%	101,729 $374,000
Q4 2020 Feb 12, 2021	BUY	$4.4 - $7.32 $24,508 - $40,772	5,570 Added 6.13%	96,426 $502,000
Q3 2020 Nov 09, 2020	BUY	$4.38 - $8.35 $87,897 - $167,567	20,068 Added 28.35%	90,856 $467,000
Q2 2020 Aug 13, 2020	BUY	$3.64 - $9.26 $26,899 - $68,431	7,390 Added 11.66%	70,788 $524,000
Q1 2020 May 14, 2020	SELL	$2.54 - $9.38 $12,644 - $46,693	-4,978 Reduced 7.28%	63,398 $250,000
Q4 2019 Feb 14, 2020	SELL	$7.07 - $9.51 $14,465 - $19,457	-2,046 Reduced 2.91%	68,376 $650,000
Q3 2019 Nov 13, 2019	SELL	$7.77 - $11.26 $12,315 - $17,847	-1,585 Reduced 2.2%	70,422 $547,000
Q2 2019 Aug 09, 2019	SELL	$7.91 - $10.25 $9,381 - $12,156	-1,186 Reduced 1.62%	72,007 $673,000
Q1 2019 May 08, 2019	BUY	$6.0 - $11.07 $79,230 - $146,179	13,205 Added 22.01%	73,193 $659,000
Q4 2018 Feb 07, 2019	SELL	$5.81 - $7.89 $5,380 - $7,306	-926 Reduced 1.52%	59,988 $367,000
Q3 2018 Nov 14, 2018	BUY	$6.57 - $8.31 $11,392 - $14,409	1,734 Added 2.93%	60,914 $460,000
Q2 2018 Aug 14, 2018	BUY	$3.93 - $8.93 $232,577 - $528,477	59,180 New	59,180 $475,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.